tiprankstipranks
Trending News
More News >
Protalix Biotherapeutics (PLX)
:PLX
US Market

Protalix (PLX) Ownership - Who Owns Protalix?

Compare
835 Followers

Protalix (PLX) Ownership Overview

1.10%0.84%2.10%0.21%95.75%
2.10% Other Institutional Investors
0.21% ETFs
95.75% Public Companies and Individual Investors
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 3.15% of the company’s stock is owned by Institutional Investors, 1.10% is owned by Insiders, and 95.75% is owned by Public Companies and Individual Investors.
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 2.94% of the company’s stock is owned by Institutional Investors, 1.10% is owned by Insiders, and 0.21% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
669,010Insider0.84%996,825
251,019Institution0.32%374,018
207,929Insider0.26%309,814
200,000Institution0.25%298,000
180,000Institution0.23%268,200
143,954Institution0.18%214,491
23,784Institution0.03%35,438
19,257Institution0.02%28,693
14,044Institution0.02%20,926
1,216Institution<0.01%1,812

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
251,019Institution0.32%374,018
200,000Institution0.25%298,000
180,000Institution0.23%268,200
23,784Institution0.03%35,438
14,044Institution0.02%20,926
1,216Institution<0.01%1,812

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
143,954Institution0.18%214,491
7,085Institution<0.01%10,557
6,327Institution<0.01%9,744
5,845Institution<0.01%9,001

FAQ

Who Owns Protalix Biotherapeutics (PLX)?
According to the latest TipRanks data, approximately 2.10% of the company's stock is held by institutional investors, 1.10% is held by insiders, and 95.75% is held by retail investors.
    What percentage of Protalix Biotherapeutics (PLX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.10% of Protalix Biotherapeutics (PLX) stock is held by institutional investors.
      What percentage of Protalix Biotherapeutics (PLX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 95.75% of Protalix Biotherapeutics (PLX) stock is held by retail investors.
        Who owns the most shares of Protalix Biotherapeutics (PLX)?
        Eyal Rubin owns the most shares of Protalix Biotherapeutics (PLX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis